These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8472624)

  • 1. Gangliosides prevent insulitis but not islet B cell destruction in low-dose streptozocin-treated mice.
    Papaccio G
    Diabetes Res Clin Pract; 1993 Jan; 19(1):9-15. PubMed ID: 8472624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructural observations on cytotoxic effector cells infiltrating pancreatic islets of low-dose streptozocin treated mice.
    Papaccio G; Esposito V
    Virchows Arch A Pathol Anat Histopathol; 1992; 420(1):5-10. PubMed ID: 1531718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An increase in superoxide dismutase counteracts islet vascular alterations in low-dose streptozocin-treated mice.
    Papaccio G; Frascatore S; Pisanti FA
    Histochemistry; 1994 Mar; 101(3):215-21. PubMed ID: 8056621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose streptozocin-induced autoimmune diabetes in islet transplantation model.
    Weide LG; Lacy PE
    Diabetes; 1991 Sep; 40(9):1157-62. PubMed ID: 1834505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of a nitric oxide synthase inhibitor does not suppress low-dose streptozotocin-induced diabetes in mice.
    Papaccio G; Esposito V; Latronico MV; Pisanti FA
    Int J Pancreatol; 1995 Feb; 17(1):63-8. PubMed ID: 8568336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early macrophage infiltration in mice treated with low-dose streptozocin decreases islet superoxide dismutase levels: prevention by silica pretreatment.
    Papaccio G; Frascatore S; Esposito V; Pisanti FA
    Acta Anat (Basel); 1991; 142(2):141-6. PubMed ID: 1664165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of islet microvasculature in mice treated with low-dose streptozocin.
    Papaccio G; Chieffi-Baccari G
    Histochemistry; 1992 May; 97(4):371-4. PubMed ID: 1535618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulation of low dose streptozocin diabetes in mice reveals that insulitis is not obligatory for B cell destruction.
    Papaccio G; Chieffi Baccari G; Esposito V
    J Anat; 1992 Dec; 181 ( Pt 3)(Pt 3):403-7. PubMed ID: 1304577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo effect of gangliosides on non-obese diabetic mice.
    Papaccio G; Chieffi Baccari G; Mezzogiorno V
    Acta Anat (Basel); 1993; 147(3):168-73. PubMed ID: 8213041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose streptozocin-induced diabetes in mice. Electron microscopy reveals single-cell insulitis before diabetes onset.
    Kolb-Bachofen V; Epstein S; Kiesel U; Kolb H
    Diabetes; 1988 Jan; 37(1):21-7. PubMed ID: 3275555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunosuppressant FK506 inhibits the damage to mouse pancreatic islets induced by low dose streptozocin.
    Papaccio G; Latronico M; Chieffi Baccari G
    Cell Tissue Res; 1994 Sep; 277(3):573-8. PubMed ID: 7525068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capillary area in early low-dose streptozocin-treated mice.
    Papaccio G; Chieffi-Baccari G; Mezzogiorno V; Esposito V
    Histochemistry; 1990; 95(1):19-21. PubMed ID: 1704876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of intrasplenically implanted islets in mice with experimental insulitis and hyperglycemia.
    Sandler S; Andersson A
    Diabetes; 1982 Aug; 31 Suppl 4():78-83. PubMed ID: 6219904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical study of insulitis induced by multiple low doses of streptozocin in CD-1 mice.
    Iwakiri R; Nagafuchi S; Kounoue E; Nakamura M; Kikuchi M; Nakano S; Niho Y
    Diabetes Res Clin Pract; 1990 Apr; 9(1):75-82. PubMed ID: 2140977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of nitric oxide generation affects the induction of diabetes by streptozocin in mice.
    Lukic ML; Stosic-Grujicic S; Ostojic N; Chan WL; Liew FY
    Biochem Biophys Res Commun; 1991 Aug; 178(3):913-20. PubMed ID: 1831356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Islet B cell neoproliferation in early low dose streptozocin induced diabetes in mice: a ducto-endocrine proliferation?
    Papaccio G; Esposito V; Mezzogiorno V
    Acta Morphol Hung; 1991; 39(1):43-52. PubMed ID: 1836928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The vitamin-E derivative U-83836-E in the low-dose streptozocin- treated mouse: effects on diabetes development.
    Papaccio G; Baccari GC; Frascatore S; Sellitti S; Pisanti FA
    Diabetes Res Clin Pract; 1995 Dec; 30(3):163-71. PubMed ID: 8861455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of streptozotocin-induced insulitis and hyperglycaemia in the mouse.
    Sandler S; Andersson A
    Acta Pathol Microbiol Immunol Scand A; 1985 Mar; 93(2):93-8. PubMed ID: 3157292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic duct infiltration in the low-dose streptozocin-treated mouse.
    Papaccio G; Strate C; Linn T
    Histol Histopathol; 1994 Jul; 9(3):529-34. PubMed ID: 7981500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple low-dose streptozocin-induced diabetes in NOD-scid/scid mice in the absence of functional lymphocytes.
    Gerling IC; Friedman H; Greiner DL; Shultz LD; Leiter EH
    Diabetes; 1994 Mar; 43(3):433-40. PubMed ID: 8314017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.